AVG Ventures

North America, California, United States, Walnut Creek

Description

AVG Ventures seeks to invest in early stage technology companies.

Investor Profile

AVG Ventures has made 9 investments, with 0 in the past 12 months and 11% as lead.

Stage Focus

Seed (44%)
Series B (33%)
Series A (11%)
Debt Financing (11%)

Country Focus

United States (67%)
Switzerland (11%)
United Kingdom (11%)
Singapore (11%)

Industry Focus

Software
B2b
Industrial Automation
Blockchain
Biotechnology
Health Care
Health Diagnostics
Oncology
Therapeutics
Gaming

FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does AVG Ventures frequently co-invest with?

Harlem Capital Partners

North America, New York, United States, New York

Co-Investments: 1

116 Street Ventures

North America, New York, United States, New York

Co-Investments: 1

Allon Ventures

North America, New York, United States, New York

Co-Investments: 1

High Alpha

North America, Indiana, United States, Indianapolis

Co-Investments: 1

Remeditex Ventures

North America, Texas, United States, Dallas

Co-Investments: 2

Interlace Ventures

North America, California, United States, San Francisco

Co-Investments: 1

Bascom Ventures

North America, New Hampshire, United States, Manchester

Co-Investments: 1

Castor Ventures

North America, Massachusetts, United States, Boston

Co-Investments: 1

Airbus Ventures

North America, California, United States, Menlo Park

Co-Investments: 1

Alumni Ventures

North America, New Hampshire, United States, Manchester

Co-Investments: 4

Which angels does AVG Ventures often collaborate with?

Paul Goodman

North America, California, United States, San Diego

Shared Deals: 1

Lachy Groom

North America, California, United States, San Francisco

Shared Deals: 1

Darwish Gani

North America, California, United States, San Francisco

Shared Deals: 1

Philippe Bubb

Europe, Zurich, Switzerland

Shared Deals: 1

James Brown

Shared Deals: 1

What are some of recent deals done by AVG Ventures?

Aztec

Winchester, Hampshire, United Kingdom

Aztec develops an ethereum trading protocol that enables private transactions across the public blockchain.

BlockchainEthereumPrivacySoftwareWeb3

Series BDec 15, 2022

Amount Raised: $99,964,647

Infinity Arena

Singapore, Central Region, Singapore

Infinity Arena, an emerging blockchain game that combines science-fiction and tactical play-to-earn (P2E) nonfungible tokens (NFTs)

BlockchainGamingMMO Games

SeedFeb 10, 2022

Amount Raised: $1,500,000

DeflyBall

Los Angeles, California, United States

DeFlyBall is a developer of a blockchain NFT gaming platform.

GamingMetaverseVideo Games

SeedDec 14, 2021

Amount Raised: $1,600,000

unspun

San Francisco, California, United States

Unspun is a fashion-tech company creating 3D weaving technology for apparel.

3D TechnologyApparelFashionIndustrial AutomationSoftwareTextiles

SeedSep 8, 2021

Amount Raised: $7,500,000

Singuli

New York, New York, United States

Singuli is an inventory optimization platform that offers spreadsheet tools for retailers.

Artificial Intelligence (AI)B2BMachine LearningRetail TechnologySaaS

SeedJun 30, 2021

Amount Raised: $3,699,998

Verity

Zürich, Zurich, Switzerland

Verity automates inventory checks in warehouses and DCs using autonomous drones for zero-error warehouses.

DronesIndustrial AutomationRoboticsSupply Chain ManagementWarehouse AutomationWarehousing

Series AJun 5, 2018

Amount Raised: $18,286,699

Bellicum Pharmaceuticals

Houston, Texas, United States

Bellicum Pharmaceuticals is a clinical-stage biopharmaceutical company that is driving the future of cellular immuno-oncology (IO).

BiotechnologyHealth CareHealth DiagnosticsOncologyTherapeutics

Series BJan 7, 2014

Amount Raised: $14,700,000

Bellicum Pharmaceuticals

Houston, Texas, United States

Bellicum Pharmaceuticals is a clinical-stage biopharmaceutical company that is driving the future of cellular immuno-oncology (IO).

BiotechnologyHealth CareHealth DiagnosticsOncologyTherapeutics

Series BMar 8, 2012

Amount Raised: $20,000,000

VisibleGains

Waltham, Massachusetts, United States

VisibleGains provides products that help businesses better communicate with their customers.

AppsB2BMessagingOnline PortalsSoftwareVideo

Debt FinancingAug 1, 2011

Amount Raised: $1,000,000

AVG Ventures

Description

Investor Profile

Stage Focus

Country Focus

Industry Focus

Frequently Asked Questions

Who does AVG Ventures frequently co-invest with?

Which angels does AVG Ventures often collaborate with?

What are some of recent deals done by AVG Ventures?

Ready to Raise Capital?

Pages

Free tools